Dmitriy N Feldman

Summary

Affiliation: Cornell University
Country: USA

Publications

  1. doi Prognostic value of cardiac troponin-I or troponin-T elevation following nonemergent percutaneous coronary intervention: a meta-analysis
    Dmitriy N Feldman
    Greenberg Division of Cardiology, New York Presbyterian Hospital, Weill Cornell Medical College, New York, New York 10021, USA
    Catheter Cardiovasc Interv 77:1020-30. 2011
  2. ncbi Impact of Chronic Statin Therapy on Postprocedural Contrast-Induced Nephropathy in Patients Undergoing Non-Emergent Percutaneous Coronary Intervention
    Jake M Chanin
    New York Presbyterian Hospital, Weill Cornell Medical College, Greenberg Division of Cardiology, 520 East 70th Street, Starr 434 Pavilion, New York, NY 10021 USA
    J Invasive Cardiol 27:490-6. 2015
  3. ncbi Innovations in drug-eluting stents
    K Nallu
    Division of Cardiology, Weill Cornell Medical College New York Presbyterian Hospital New York, New York, USA
    Panminerva Med 55:345-52. 2013
  4. doi Adoption of radial access and comparison of outcomes to femoral access in percutaneous coronary intervention: an updated report from the national cardiovascular data registry (2007-2012)
    Dmitriy N Feldman
    Weill Cornell Medical College, New York Presbyterian Hospital, Department of Medicine, Greenberg Division of Cardiology, 520 E 70th St, Starr 434 Pavilion, New York, NY 10021, USA
    Circulation 127:2295-306. 2013
  5. ncbi Reperfusion therapy in ST-elevation myocardial infarction: guidelines, strategies, pharmacology, and stent selection
    B D Ghosh
    Department of Medicine, New York Presbyterian Hospital, New York, NY, USA
    Minerva Med 103:431-9. 2012
  6. doi Efficacy and safety of bivalirudin in patients receiving clopidogrel therapy after diagnostic angiography for percutaneous coronary intervention in acute coronary syndromes
    Dmitriy N Feldman
    Greenberg Division of Cardiology, New York Presbyterian Hospital, Weill Cornell Medical College, New York, New York 10021, USA
    Catheter Cardiovasc Interv 76:513-24. 2010
  7. doi Efficacy of high-dose clopidogrel treatment (600 mg) less than two hours before percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes
    Dmitriy N Feldman
    Greenberg Division of Cardiology, New York Presbyterian Hospital, Weill Cornell Medical College, New York, New York, USA
    Am J Cardiol 105:323-32. 2010
  8. doi Relation of troponin I levels following nonemergent percutaneous coronary intervention to short- and long-term outcomes
    Dmitriy N Feldman
    New York Presbyterian Hospital, Weill Cornell Medical College, New York, USA
    Am J Cardiol 104:1210-5. 2009
  9. ncbi Frequency and outcomes of provisional glycoprotein IIb/IIIa blockade in patients receiving bivalirudin during percutaneous coronary intervention
    Dmitriy N Feldman
    New York Presbyterian Hospital, Weill Cornell Medical College, Greenberg Division of Cardiology, 520 East 70th Street, Starr 434 Pavilion, New York, NY 10021, USA
    J Invasive Cardiol 21:258-63. 2009
  10. ncbi Impact of bivalirudin on outcomes after percutaneous coronary revascularization with drug-eluting stents
    Dmitriy N Feldman
    Division of Cardiology, New York Presbyterian Hospital Weill Medical College of Cornell University, New York, NY 10021, USA
    Am Heart J 154:695-701. 2007

Collaborators

Detail Information

Publications49

  1. doi Prognostic value of cardiac troponin-I or troponin-T elevation following nonemergent percutaneous coronary intervention: a meta-analysis
    Dmitriy N Feldman
    Greenberg Division of Cardiology, New York Presbyterian Hospital, Weill Cornell Medical College, New York, New York 10021, USA
    Catheter Cardiovasc Interv 77:1020-30. 2011
    ..The aim of this meta-analysis was to assess the prevalence and prognostic value regarding mortality of cTnT or cTnI elevations after nonemergent percutaneous coronary intervention (PCI) in a large number of cohort/registry studies...
  2. ncbi Impact of Chronic Statin Therapy on Postprocedural Contrast-Induced Nephropathy in Patients Undergoing Non-Emergent Percutaneous Coronary Intervention
    Jake M Chanin
    New York Presbyterian Hospital, Weill Cornell Medical College, Greenberg Division of Cardiology, 520 East 70th Street, Starr 434 Pavilion, New York, NY 10021 USA
    J Invasive Cardiol 27:490-6. 2015
    ....
  3. ncbi Innovations in drug-eluting stents
    K Nallu
    Division of Cardiology, Weill Cornell Medical College New York Presbyterian Hospital New York, New York, USA
    Panminerva Med 55:345-52. 2013
    ..This comprehensive review will discuss the evolution of intracoronary stents from their introduction to current utilization of DES as well as future research on bioabsorbable stents and polymers. ..
  4. doi Adoption of radial access and comparison of outcomes to femoral access in percutaneous coronary intervention: an updated report from the national cardiovascular data registry (2007-2012)
    Dmitriy N Feldman
    Weill Cornell Medical College, New York Presbyterian Hospital, Department of Medicine, Greenberg Division of Cardiology, 520 E 70th St, Starr 434 Pavilion, New York, NY 10021, USA
    Circulation 127:2295-306. 2013
    ..Our aims were to evaluate temporal trends in r-PCI and compare procedural outcomes between r-PCI and transfemoral PCI...
  5. ncbi Reperfusion therapy in ST-elevation myocardial infarction: guidelines, strategies, pharmacology, and stent selection
    B D Ghosh
    Department of Medicine, New York Presbyterian Hospital, New York, NY, USA
    Minerva Med 103:431-9. 2012
    ..This review will discuss the current STEMI guidelines and strategies, recent advances in pharmacotherapy, and data on stent selection...
  6. doi Efficacy and safety of bivalirudin in patients receiving clopidogrel therapy after diagnostic angiography for percutaneous coronary intervention in acute coronary syndromes
    Dmitriy N Feldman
    Greenberg Division of Cardiology, New York Presbyterian Hospital, Weill Cornell Medical College, New York, New York 10021, USA
    Catheter Cardiovasc Interv 76:513-24. 2010
    ..This study sought to investigate if the efficacy of bivalirudin monotherapy is similar to heparin plus GP IIb/IIIa inhibition in patients with acute coronary syndromes (ACS) treated with clopidogrel following diagnostic angiography...
  7. doi Efficacy of high-dose clopidogrel treatment (600 mg) less than two hours before percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes
    Dmitriy N Feldman
    Greenberg Division of Cardiology, New York Presbyterian Hospital, Weill Cornell Medical College, New York, New York, USA
    Am J Cardiol 105:323-32. 2010
    ..927). In conclusion, treatment with a 600-mg loading dose <2 hours before PCI is associated with similar short-term ischemic outcomes and long-term mortality compared to the currently recommended clopidogrel pretreatment regimen...
  8. doi Relation of troponin I levels following nonemergent percutaneous coronary intervention to short- and long-term outcomes
    Dmitriy N Feldman
    New York Presbyterian Hospital, Weill Cornell Medical College, New York, USA
    Am J Cardiol 104:1210-5. 2009
    ....
  9. ncbi Frequency and outcomes of provisional glycoprotein IIb/IIIa blockade in patients receiving bivalirudin during percutaneous coronary intervention
    Dmitriy N Feldman
    New York Presbyterian Hospital, Weill Cornell Medical College, Greenberg Division of Cardiology, 520 East 70th Street, Starr 434 Pavilion, New York, NY 10021, USA
    J Invasive Cardiol 21:258-63. 2009
    ....
  10. ncbi Impact of bivalirudin on outcomes after percutaneous coronary revascularization with drug-eluting stents
    Dmitriy N Feldman
    Division of Cardiology, New York Presbyterian Hospital Weill Medical College of Cornell University, New York, NY 10021, USA
    Am Heart J 154:695-701. 2007
    ..We investigated whether long-term outcomes after bivalirudin use remained comparable to heparin plus GP IIb/IIIa blockade in current clinical practice of drug-eluting stent use...
  11. ncbi Efficacy and safety of bivalirudin in patients with diabetes mellitus undergoing percutaneous coronary intervention in current clinical practice
    Luke K Kim
    New York Presbyterian Hospital, Weill Cornell Medical College, Greenberg Division of Cardiology, 520 East 70th Street, New York, NY 10021, USA
    J Invasive Cardiol 22:94-100. 2010
    ..This study sought to evaluate the short- and long-term efficacy and safety of bivalirudin in diabetic patients undergoing percutaneous coronary intervention (PCI) in contemporary clinical practice...
  12. doi Nonsystem reasons for delay in door-to-balloon time and associated in-hospital mortality: a report from the National Cardiovascular Data Registry
    Rajesh V Swaminathan
    New York Presbyterian Hospital, Weill Cornell Medical College, Greenberg Division of Cardiology, New York, New York, USA
    J Am Coll Cardiol 61:1688-95. 2013
    ..The goal of this study was to characterize nonsystem reasons for delay in door-to-balloon time (D2BT) and the impact on in-hospital mortality...
  13. ncbi Impact of peripheral vascular disease on short- and long-term outcomes in patients undergoing non-emergent percutaneous coronary intervention in the drug-eluting stent era
    Scott Midwall
    Greenberg Division of Cardiology, Weill Cornell Medical College, New York Presbyterian Hospital, New York, New York 10021, USA
    J Invasive Cardiol 25:132-6. 2013
    ..This study sought to compare short- and long-term (4-year) outcomes in patients with and without peripheral vascular disease (PVD) following non-emergent percutaneous coronary intervention (PCI) in current clinical practice...
  14. doi Clinical presentation, management, and outcomes of angiographically documented early, late, and very late stent thrombosis
    Ehrin J Armstrong
    Division of Cardiology, University of California, Davis Medical Center, Sacramento, California 95817, USA
    JACC Cardiovasc Interv 5:131-40. 2012
    ..The aim of this study was to describe differences in treatment and in-hospital mortality of early, late, and very late stent thrombosis (ST)...
  15. pmc Outcome of the HORIZONS-AMI trial: bivalirudin enhances long-term survival in patients with ST-elevation myocardial infarction undergoing angioplasty
    Ashish Shah
    Greenberg Division of Cardiology, New York Presbyterian Hospital, Weill Cornell Medical College, New York, NY 10021, USA
    Vasc Health Risk Manag 8:115-23. 2012
    ..These results further support the use of bivalirudin in the setting of primary PCI for STEMI given that its benefits are maintained through long-term follow-up...
  16. ncbi Outcomes following immediate (ad hoc) versus staged percutaneous coronary interventions (report from the 2000 to 2001 New York State Angioplasty Registry)
    Dmitriy N Feldman
    Division of Cardiology, New York Presbyterian Hospital Weill Medical College of Cornell University, New York, New York, USA
    Am J Cardiol 99:446-9. 2007
    ..In conclusion, as currently practiced in New York State, the strategy of ad hoc PCI in selected patient cohorts appears to be as safe as the strategy of staged procedures...
  17. pmc Door-to-balloon time in primary percutaneous coronary intervention predicts degree of myocardial necrosis as measured using cardiac biomarkers
    Robert M Minutello
    Department of Medicine, Division of Cardiology, Weill Cornell Medical College, New York, New York 10065, USA
    Tex Heart Inst J 37:161-5. 2010
    ....
  18. doi Comparison of Trends in Incidence, Revascularization, and In-Hospital Mortality in ST-Elevation Myocardial Infarction in Patients With Versus Without Severe Mental Illness
    Joshua Schulman-Marcus
    Department of Medicine, Weill Cornell Medical College, New York, New York Department of Radiology, Weill Cornell Medical College, New York, New York Electronic address
    Am J Cardiol 117:1405-10. 2016
    ..16). In conclusion, in contrast to the overall population, the incidence of STEMI is not decreasing in patients with SMI. Despite changes in the care of STEMI, patients with SMI remain less likely to receive revascularization therapies...
  19. doi Trends in hospital treatments for peripheral arterial disease in the United States and association between payer status and quality of care/outcomes, 2007-2011
    Luke K Kim
    Division of Cardiology, Weill Cornell Medical College, New York Presbyterian Hospital, New York, New York
    Catheter Cardiovasc Interv 86:864-72. 2015
    ..This study sought to identify the temporal trends of presenting diagnoses and vascular procedures performed for peripheral arterial disease (PAD) along with the rates of procedures and in-hospital outcomes by payer status...
  20. doi Hospital Volume Outcomes After Septal Myectomy and Alcohol Septal Ablation for Treatment of Obstructive Hypertrophic Cardiomyopathy: US Nationwide Inpatient Database, 2003-2011
    Luke K Kim
    Division of Cardiology, Department of Medicine, Weill Cornell Medical College, New York Presbyterian Hospital, New York
    JAMA Cardiol 1:324-32. 2016
    ..Use of septal reduction therapy and the effect of institutional experience on procedural outcomes nationally are unknown...
  21. doi Association Between Transcatheter Aortic Valve Implantation Volume and Outcomes in the United States
    Luke K Kim
    Division of Cardiology, Department of Internal Medicine, Weill Cornell Medical College, New York Presbyterian Hospital, New York, New York Electronic address
    Am J Cardiol 116:1910-5. 2015
    ..6% vs 2.3%, p <0.001). In conclusion, centers with lower volume of TAVI had more frequent adverse events compared with higher volume centers. ..
  22. doi Pharmacotherapy for the reduction of stent thrombosis
    David C Yang
    Weill Cornell Medical College, New York Presbyterian Hospital, Department of Medicine, Greenberg Division of Cardiology, 520 East 70th Street, Starr 434 Pavilion, New York, NY 10021, USA
    Expert Rev Cardiovasc Ther 11:567-76. 2013
    ..In this review, evidence related to the various pharmacological agents for reduction of stent thrombosis available to clinicians during and after PCI will be explored...
  23. doi Impact of long-term statin therapy on postprocedural myocardial infarction in patients undergoing nonemergency percutaneous coronary intervention
    Jonathan Gordin
    Greenberg Division of Cardiology, New York Presbyterian Hospital, Weill Cornell Medical College, New York, NY, USA
    Am J Cardiol 110:1397-404. 2012
    ..In patients with unstable coronary syndromes, long-term statin therapy may be beneficial, particularly at a high dose...
  24. doi Analysis of reperfusion time trends in patients with ST-elevation myocardial infarction across New York State from 2004 to 2012
    Subhi J Al'aref
    Division of Cardiology, Department of Medicine, NewYork Presbyterian Hospital Weill Cornell Medical Center, New York, NY 10065, United States
    Int J Cardiol . 2017
    ..We sought to determine the trends in reperfusion times (symptom-onset to door (SOTD) and DTB times) in patients presenting with STEMI across New York State...
  25. doi Prognostic Importance of Diastolic Dysfunction in Relation to Post Procedural Aortic Insufficiency in Patients Undergoing Transcatheter Aortic Valve Replacement
    Polydoros N Kampaktsis
    William Acquavella Heart Valve Center, New York Presbyterian Hospital Weill Cornell Medical College, New York, New York
    Catheter Cardiovasc Interv . 2016
    ..We sought to examine whether baseline diastolic dysfunction (DD) is associated with increased mortality in patients who develop aortic insufficiency (AI) after transcatheter aortic valve replacement (TAVR)...
  26. pmc Sex-Based Disparities in Incidence, Treatment, and Outcomes of Cardiac Arrest in the United States, 2003-2012
    Luke K Kim
    Division of Cardiology, Weill Cornell Medical College, New York Presbyterian Hospital, New York, NY
    J Am Heart Assoc 5:. 2016
    ..Recent studies have shown improving survival after cardiac arrest. However, data regarding sex-based disparities in treatment and outcomes after cardiac arrest are limited...
  27. ncbi Comparison of outcomes of percutaneous coronary interventions in patients of three age groups (<60, 60 to 80, and >80 years) (from the New York State Angioplasty Registry)
    Dmitriy N Feldman
    Division of Cardiology, New York Presbyterian Hospital Weill Medical College of Cornell University, New York, New York, USA
    Am J Cardiol 98:1334-9. 2006
    ..Elderly patients, in particular octogenarians undergoing emergency PCI, have a substantially higher risk of in-hospital death...
  28. doi Novel antiplatelet therapies
    Luke Kim
    Greenberg Division of Cardiology, New York Presbyterian Hospital, Weill Cornell Medical College, 520 East 70th Street, Starr 434 Pavilion, New York, NY 10021, USA
    Curr Atheroscler Rep 14:78-84. 2012
    ..The field of pharmacotherapy continues to rapidly evolve as newer agents, such as thrombin receptor antagonists, along with older agents, such as cilostazol and glycoprotein IIb/IIIa inhibitors, are being explored...
  29. doi Hospital length of stay and clinical outcomes in older STEMI patients after primary PCI: a report from the National Cardiovascular Data Registry
    Rajesh V Swaminathan
    Weill Cornell Medical College, New York Presbyterian Hospital, Greenberg Division of Cardiology, New York, New York Electronic address
    J Am Coll Cardiol 65:1161-71. 2015
    ..There has been a decline in hospital length of stay (LOS) after primary percutaneous coronary intervention (PPCI) for ST-segment elevation myocardial infarction (STEMI)...
  30. doi Costs and in-hospital outcomes of transcatheter aortic valve implantation versus surgical aortic valve replacement in commercial cases using a propensity score matched model
    Robert M Minutello
    Division of Cardiology, Weill Cornell Medical College, New York Presbyterian Hospital, New York, New York Electronic address
    Am J Cardiol 115:1443-7. 2015
    ....
  31. doi Rate of percutaneous coronary intervention for the management of acute coronary syndromes and stable coronary artery disease in the United States (2007 to 2011)
    Luke K Kim
    Division of Cardiology, Department of Medicine, Weill Cornell Medical College, New York Presbyterian Hospital, New York, New York Electronic address
    Am J Cardiol 114:1003-10. 2014
    ..5%, p=0.03 and 59.5%, p=0.007, respectively). In conclusion, the rate of PCI decreased substantially starting from 2009 in the United States. Most of the decrease was attributed to the reduction in PCI utilization for stable CAD...
  32. doi Comparison of trends and outcomes of carotid artery stenting and endarterectomy in the United States, 2001 to 2010
    Luke K Kim
    From the Division of Cardiology, Weill Cornell Medical College, New York Presbyterian Hospital L K K, D C Y, R V S, R M M, P M O, S C W, G B, H S, D N F Department of Developmental Biology, Harvard School of Dental Medicine, Boston, MA M K L Division of Biostatistics and Epidemiology, Department of Public Health, Weill Medical College of Cornell University, New York, NY X S Department of Cardiovascular Medicine, Pennsylvania Hospital University of Pennsylvania Health System, Philadelphia D J M and Department of Orthodontics College of Dentistry, University of Iowa, Iowa City V A
    Circ Cardiovasc Interv 7:692-700. 2014
    ....
  33. ncbi A strategy of 'treating through' a prasugrel-induced rash
    David C Yang
    Weill Medical College of Cornell University, Greenberg Division of Cardiology, New York, NY, United States
    Int J Cardiol . 2013
  34. doi Characteristics of Hospitalizations for Heart Failure with Preserved Ejection Fraction
    Parag Goyal
    Division of Cardiology, Weill Cornell Medical College, New York, NY Electronic address
    Am J Med 129:635.e15-26. 2016
    ..Hospitalizations for heart failure with preserved ejection fraction (HFpEF) are increasing. There are limited data examining national trends in patients hospitalized with HFpEF...
  35. doi Gender Differences in In-Hospital Outcomes After Coronary Artery Bypass Grafting
    Rajesh V Swaminathan
    Greenberg Division of Cardiology, New York Presbyterian Hospital, Weill Cornell Medical College, New York, New York Electronic address
    Am J Cardiol 118:362-8. 2016
    ..001) from 2003 to 2012. In conclusion, CABG rates in the United States are decreasing over time, yet in-hospital mortality continues to improve. Women have worse in-hospital outcomes than men; however, the gender gap is slowly closing. ..
  36. doi Comparison of Recent Trends in Patients With and Without Major Depression and Acute ST-Elevation Myocardial Infarction
    Joshua Schulman-Marcus
    Department of Medicine, Weill Cornell Medical College, New York, New York Department of Radiology, Weill Cornell Medical College, New York, New York Electronic address
    Am J Cardiol 118:779-84. 2016
    ..Patients with STEMI and co-morbid depression are less likely to receive revascularization therapy with PCI. These concerning differences warrant further attention. ..
  37. doi Characteristics of Patients Undergoing Cardiac Catheterization Before Noncardiac Surgery: A Report From the National Cardiovascular Data Registry CathPCI Registry
    Joshua Schulman-Marcus
    Department of Medicine, Weill Cornell Medical College, New York, New York
    JAMA Intern Med 176:611-8. 2016
    ..Many patients undergo cardiac catheterization and/or percutaneous coronary intervention (PCI) before noncardiac surgery even though these procedures are not routinely indicated. Data on this cohort of patients are limited...
  38. doi Five-year mortality outcomes in patients with chronic kidney disease undergoing percutaneous coronary intervention
    Agam D Patel
    Division of Cardiology, New York Presbyterian Hospital Weill Cornell Medicine, New York, New York
    Catheter Cardiovasc Interv . 2016
    ..To examine peri-procedural and long-term outcomes in patients with chronic kidney disease (CKD) undergoing percutaneous coronary interventions (PCI)...
  39. ncbi Impact of Paravalvular Aortic Insufficiency on Left Ventricular Remodeling and Mortality after Transcatheter Aortic Valve Replacement
    Polydoros N Kampaktsis
    William Acquavella Heart Valve Center, New York Presbyterian Hospital Weill Cornell Medical College, New York, USA
    J Heart Valve Dis 25:301-308. 2016
    ..The aim of the present study was to examine the association between PAR, LV remodeling and mortality following TAVR in a non-PARTNER (Placement of Aortic Transcatheter Valves) trial population...
  40. doi Outcomes in patients undergoing coronary artery bypass graft surgery in the United States based on hospital volume, 2007 to 2011
    Luke K Kim
    Division of Cardiology, Department of Medicine, Weill Cornell Medical College, New York Presbyterian Hospital, New York, NY Electronic address
    J Thorac Cardiovasc Surg 151:1686-92. 2016
    ..To examine national trends in coronary artery bypass grafting (CABG) volume between 2007 and 2011, and analyze in-hospital outcomes after CABG surgery stratified according to hospital volume...
  41. ncbi Long-term clinical benefit of sirolimus-eluting stents compared to bare metal stents in the treatment of saphenous vein graft disease
    Robert M Minutello
    New York Presbyterian Hospital, Weill Cornell Campus, New York, New York, USA
    J Interv Cardiol 20:458-65. 2007
    ..The purpose of this study was to evaluate the efficacy of sirolimus-eluting stents (SES) in the treatment of saphenous vein graft (SVG) disease...
  42. pmc Transapical transcatheter aortic valve replacement in patients with or without prior coronary artery bypass graft operation
    Konstantinos V Voudris
    William Acquavella Heart Valve Center, New York Presbyterian Hospital Weill Cornell Medical College, 525 East 68th St, New York, NY, USA
    J Cardiothorac Surg 11:158. 2016
    ..The impact of prior coronary artery bypass grafting (CABG) on clinical outcomes in patients undergoing TA-TAVR is not well defined...
  43. doi Coronary Angiography and Revascularization Prior to Noncardiac Surgery
    Joshua Schulman-Marcus
    Departments of Medicine and Radiology, Weill Cornell Medical College, 1305 York Ave, 8th Avenue, New York, NY, 10021, USA
    Curr Treat Options Cardiovasc Med 18:3. 2016
    ..In summary, substantial evidence gaps warrant further research in this important area...
  44. ncbi Aneurysms of the sinuses of Valsalva
    Dmitriy N Feldman
    Division of Cardiology, New York Presbyterian Hospital Weill Medical College of Cornell University, NY 10021, USA
    Cardiology 106:73-81. 2006
    ..A review of the literature is presented focusing on anatomy, clinical presentation of ruptured and unruptured aneurysms, noninvasive diagnostic modalities, and techniques for repair of this anomaly...
  45. doi In-Stent Restenosis: Pathophysiology and Treatment
    Patrick M Looser
    Department of Medicine, Greenberg Division of Cardiology, Weill Cornell Medical College, New York Presbyterian Hospital, 520 East 70th St, Starr 4, New York, NY, 10021, USA
    Curr Treat Options Cardiovasc Med 18:10. 2016
    ..Here, we discuss the underlying pathology, risk factors, and clinical presentation of ISR while examining the evidence supporting the optimal interventional techniques for this commonly encountered clinical entity...
  46. ncbi Images in cardiology: macroscopic T-wave alternans
    Dmitriy N Feldman
    Division of Cardiology, New York Presbyterian Hospital Weill Medical College of Cornell University, New York, New York, USA
    Clin Cardiol 29:422. 2006
  47. pmc Ruptured aneurysm of the right sinus of valsalva associated with a ventricular septal defect and an anomalous coronary artery
    Dmitriy N Feldman
    Division of Cardiology, Weill Medical College of Cornell University, 525 East 68th Street, New York, New York 1002, USA
    Tex Heart Inst J 32:555-9. 2005
    ..Previously published reports of the coexistence of a single coronary artery with a sinus of Valsalva aneurysm or with a ventricular septal defect, and their management, are discussed herein...
  48. doi Continuation of Dual-Antiplatelet Therapy Following Percutaneous Revascularization with a Drug-Eluting Stent: What Duration Is Optimal?
    Rupa K Patil
    Department of Medicine, Greenberg Division of Cardiology, Weill Cornell Medical College, New York Presbyterian Hospital, 520 East 70th Street, Starr 434 Pavilion, New York, NY, 10021, USA
    Curr Atheroscler Rep 17:63. 2015
    ..We will review the data supporting current recommendations for DAPT and recent clinical trials comparing varying DAPT durations and discuss patient- and procedure-specific factors affecting the "optimal" DAPT duration...
  49. doi Unplanned staged hybrid management of postmyocardial infarction ventricular septal defect
    Dimitrios V Avgerinos
    Department of Cardiothoracic Surgery, New York Presbyterian Hospital Weill Cornell Medical Center, New York, NY, USA
    Cardiology 118:38-41. 2011
    ..This case demonstrates the successful application of an unplanned, staged hybrid approach utilizing initial percutaneous and subsequent surgical repair after recovery of tissue integrity...